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Edited by Ned ManteiAbstract The Sox6 gene is a member of the Sox gene family,
which encodes transcription factors, and previous studies have
suggested that it plays an important role in the development of
the central nervous system. Aggregation of embryonic carcinoma
P19 cells with retinoic acid (RA) results in the development of
neurons, glia, and ﬁbroblast-like cells. Sox6 mRNA increases
rapidly in P19 cells during RA induction and then decreases
during diﬀerentiation into neuronal cells. To investigate whether
Sox6 expression is essential for neuronal diﬀerentiation, we
established Sox6-suppressed P19 (P19[anti-Sox6]) cells by
transfection of antisense-Sox6 cDNA. Most of the P19[anti-
Sox6] cells showed no neurites and were not stained by the anti-
MAP 2 antibody, while the suppression of Sox6 expression
nearly totally blocked neuronal diﬀerentiation in P19 cells.
Further, Sox6 suppression caused RA-dependent apoptosis by
P19[anti-Sox6] cells: RA-treated P19[anti-Sox6] cells showed
chromatin condensation, DNA fragmentation, and an increase in
caspase-3-like activity. Thus, Sox6 is considered essential for
neuronal diﬀerentiation and may play an important role in the
early stages of neuronal diﬀerentiation or apoptosis.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Sox proteins are important factors in neurogenesis [1],
among which Sox2 and 3 are mainly expressed in the devel-
oping central nervous system, while Sox6 plays a role in the
early stage of the developing nervous system, as it is speciﬁ-
cally expressed during the initial stage (9.5–12.5 days post-
coitus) of mouse embryogenesis [2]. Sox6 was initially isolated
from an adult mouse testis cDNA library [2,3], after which we
isolated cDNA encoding a rat homolog of the previously
characterized mouse Sox6 [4]. Recently, a Sox6 null mutant* Corresponding author. Fax: +81-78-974-5689.
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doi:10.1016/j.febslet.2004.09.063was produced in mice and results of that study showed that
Sox6 protein is involved in maintaining the normal physio-
logical function of muscle tissues, such as of the heart [5].
However, the exact role of Sox6 during development of the
central nervous system remains to be elucidated.
Mouse embryonal carcinoma cells (P19 cells) have been
extensively used as a model system for in vitro diﬀerentiation
of neuronal cells, as well as skeletal and cardiac muscle cells
[6]. Following treatment with retinoic acid (RA) and cellular
aggregation, P19 cells diﬀerentiate into neurons and glia,
though they form skeletal or cardiac muscle, endoderm, and
other cell types under diﬀerent conditions [6]. In studies of
neurogenesis, gene-transfected P19 cells have been found use-
ful [7,8]. Since numerous genes are activated in P19 cells in
response to RA, we previously investigated whether Sox6 can
directly induce neuronal cells from P19 cells. In that study, we
produced P19[Sox6] cells that overexpressed P19, which caused
remarkable cellular aggregation and diﬀerentiation into neu-
ronal cells in the absence of RA [9].
In the present study, we used an antisense Sox6 suppression
approach to determine whether Sox6 expression is essential for
neuronal diﬀerentiation by P19 cells. We found that the ex-
pression of antisense Sox6 RNA induced RA-dependent ap-
optosis and blocked the diﬀerentiation of P19 cells into
neuronal cells by RA.2. Materials and methods
2.1. Tissue culture
A P19 EC cell line was purchased from American Type Culture
Collection, then maintained in a-modiﬁed minimum essential medium
supplemented with 2.5% fetal bovine serum (FBS) and 7.5% calf serum
(CS). For the induction of neuronal cells, P19 cells were cultured in
bacterial grade dishes (IWAKI) in the presence of 500 nM of RA for 4
days. Cells were ﬂoated on the dishes and formed large aggregates,
which were trypsinized for dispersion and re-plated in poly-ornithine-
coated tissue culture dishes or transferred to coverslips without RA for
5–7 days.
2.2. Plasmid DNA and transfection
Sox6 cDNA was kindly provided by Dr. Shinya Yamashita (Nippon
Suisan Kaisya Ltd, Tokyo, Japan). To generate an antisense Sox6
construct, Sox6 fragments were ampliﬁed by PCR using the restriction
site tagging primers 50-caaagcttcctctccatccgc-30 and 50-gat-
ctagattacagatgtgcgtctgg-30. The HindIII/XbaI fragment of the Sox6
PCR products was reverse inserted into the XbaI/HindIII site of ablished by Elsevier B.V. All rights reserved.
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Sox6 expression vectors were transfected into P19 cells and stable
transfectants were obtained following selection with 500 lg/ml of G418
(Nakarai, Kyoto, Japan) for 14 days. A pcDNA3.1 LacZ vector (In-
vitrogen, San Diego, CA) was transfected into P19 cells using the same
procedure as for the antisense Sox6 expression vectors.
2.3. Immunocytochemistry
An immunocytochemical study was carried out as previously de-
scribed [9]. Brieﬂy, cells were ﬁxed with 4% paraformaldehyde in PBS,
dehydrated with 5% acetic acid in methanol, and permeabilized with
Triton X-100/Tris-buﬀered saline. They were stained with monoclonal
microtubule-associated-protein 2 (MAP2) antibodies (1:500) (Amer-
sham) or normal mouse serum.
2.4. Cell count
The cells were then cultured in tissue culture grade dishes in the
presence of RA for 24 or 48 h, treated with trypsin for collection, re-
suspended in Tripton solution, and counted using a Coulter counter.
2.5. Nuclear staining
Cells were cultured in 24-well plates as ﬂoating cultures in the
presence of RA for 24 or 48 h. They were then exposed to 1 ng/ml of
Hoechst 33342, to stain nuclei of living cells, and 2 ng/ml of propi-
dium iodide (PI), to stain nuclei of dead cells, for 30 min at room
temperature.
2.6. Isolation of fragmented DNA
To examine DNA fragmentation, approximately 106 cells were cul-
tured in bacterial grade dishes in the presence of RA for 48 h. The cells
were then harvested, washed twice with PBS, and used for DNA iso-
lation. Next, they were added to 100 ll of lysis buﬀer (10 mM Tris–
HCl buﬀer, pH 7.4, containing 10 mM EDTA and 0.5% Triton X-100),
incubated for 10 min at 4 C, and centrifuged at 16 000 rpm for 20 min
at 4 C. The supernatant was treated with 200 lg/ml of RNase A for 1
h at 37 C and then with 200 lg/ml of proteinase K for 1 h at 37 C.
Twenty microliters of 5 M NaCl and 120 ll of isopropanol were added
to 200 ll of supernatant, and then incubated overnight at )20 C and
centrifuged at 16 000 rpm for 20 min at 4 C. The pellets were dried
and dissolved in 20 ll of TE buﬀer (10 mM Tris–HCl buﬀer, pH 7.4
and containing 1 mM EDTA). DNA ladders were visualized by run-
ning 20 ll on a 2% agarose gel, with a 123-bp ladder used as the
standard.Fig. 1. Suppression of Sox6 mRNA expression by anti-Sox6. (A) Schematic d
fragments were ampliﬁed by PCR using restriction site tagging primers show
transfected P19 cells. RNA was isolated from cells cultured in tissue culture
using anti-Sox6 primers. (C) Suppression of Sox6 mRNA in P19[anti-Sox6
bacterial grade dishes for 4 days (Day )4 to Day 0) and then re-plated in po
was isolated from the cells and then subjected to RT-PCR analysis using S
positive control for reverse transcriptation.2.7. Caspase-3-like activity
Approximately 106 cells were cultured in bacterial grade dishes in the
presence or absence of RA for 48 h. After incubation, the cells were
washed twice with PBS and lysed in PBS containing 0.2% Triton X-100
on ice for 10 min. After centrifugation at 10 000 g for 20 min, cell
extracts were measured for Ac-DEVD-pNA cleavage activity using a
Caspase-3 Colorimetric Activity Assay Kit (Chemicon), according to
the manufacturer’s instructions.
2.8. RT-PCR analysis
The expression of Oct-3/4, Wnt-1, Mash-1, N-cadherin and Sox6
was measured by semiquantitative RT-PCR as previously described
[9]. RT-PCR was performed using MulV RNA polymerase (Perkin–
Elmer) and Taq polymerase (Perkin–Elmer) as described in the
manufacturer’s manual. The ﬁrst strand cDNA was synthesized using
oligo(dT) primer. PCR ampliﬁcation was performed using the syn-
thesized cDNA as a template. For the internal control, the synthesized
cDNA was ampliﬁed with glyceraldehydes-3-phosphate dehydroge-
nase (G3PDH)-speciﬁc primers. The oligonucleotides used were as
follows: 50-tacagcagcacaagatta-30 and 50-cgtgttccttctcagt-30 for Sox6;
50-tttgtgttagcctgcgagttac-30 and 50-ttagacagttgcgagagacaccat-30 for an-
ti-Sox6; 50-tgaaggtcggtcggtgtgaacggatttggc-30 and 50-catgtaggccatgagg-
tccaccac-30 for G3PDH.3. Results
3.1. Antisense-Sox6 (anti-Sox6) suppressed RA-induced
endogenous Sox6 expression
To suppress endogenous Sox6 expression, we constructed an
anti-Sox6 expression vector (Fig. 1A) and transfected it into
P19 cells. A cytomegalovirus (CMV) promoter-driven expres-
sion vector for anti-Sox6 was constructed by inserting a 1-kb
Sox6 fragment in reverse orientation into the mammalian ex-
pression vector pcDNA3.1/myc/his. After G418 selection for 2
weeks, 10 clones were isolated by limiting dilution. Anti-Sox6
mRNA expression in two isolated clones with high expression
levels of the exogenous gene is shown in Fig. 1B. The expres-
sion of anti-Sox6 was detected in clones 2–5 and 2–8, whereasiagram of Sox6 cDNA structure and an anti-Sox6 fragment. Anti-Sox6
n in the open frame of antisense-Sox6. (B) Expression of anti-Sox6 in
grade dishes in the absence of RA and subjected to RT-PCR analysis
] cells treated with RA. Cells were cultured in the presence of RA in
ly-ornithine-coated dishes for neuronal diﬀerentiation at Day 0. RNA
ox6 primers. Sox6 cDNA used as a PCR control and G3PDH was a
Fig. 2. Failure of neuronal diﬀerentiation in P19[anti-Sox6] cells. (A–D) Cells were cultured in bacterial grade dishes in the presence of RA for 4 days
and transferred to poly-ornithine-coated coverslips for 5 days. The cells were ﬁxed for immuno-staining with an anti-MAP2 antibody. (A) Clones 2–5
from P19[anti-Sox6] cells, (B) clones 2–8 from P19[anti-Sox6] cells, (C) P19[LacZ] cells stained with anti-MAP2 antibody as a positive control,
(D) P19[LacZ] cells stained with normal mouse serum as a negative control. (E) RT-PCR analysis of Oct-3/4, Wnt-1, Mash-1, and N-cadherin during
neuronal diﬀerentiation of P19 and P19[anti-Sox6] cells. Cells were cultured in bacterial grade dishes in the presence of RA for 4 days (Day )4 to Day
0), then transferred to poly-ornithine-coated coverslips for 5 days (Day 5). Taking the value for P19 at Day 0 as 100%, the relative level of expression
is shown.
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Fig. 3. Sox6 suppression decreased cellular aggregation and increased
cell death in the presence of RA. Cells were cultured in the presence of
RA in bacterial grade dishes for 4 days and observed using phase-
contrast microscopy. Upper panels: P19[LacZ] cells; lower panels:
clones 2–8 from P19[anti-Sox6] cells. Left panels: Cells without RA
treatment in tissue culture dishes; right panels: 2 days following RA
treatment in bacterial grade dishes.
Fig. 4. Growth curves of P19[anti-Sox6] cells cultured with or without
RA. Cells were cultured in tissue culture grade dishes in the presence or
absence of RA for 2 or 4 days, after which they were treated with
trypsin for collection, re-suspended in Tripton solution, and counted
using a Coulter counter. Without RA: open symbols; open circle;
P19[LacZ] cells, open triangle; clones 2–5 from P19[anti-Sox6] cells,
open square; clones 2–8 from P19[anti-Sox6] cells. With RA: closed
symbols; closed circle; P19[LacZ] cells, closed triangle; clones 2–5 from
P19[anti-Sox6] cells, closed square; clones 2–8 from P19[anti-Sox6]
cells.
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the expressed anti-Sox6 suppressed endogenous Sox6 mRNA,
the clones were treated with RA to induce Sox6 mRNA
(Fig. 1C). In P19[LacZ] cells, endogenous Sox6 was highly
induced by RA and cellular aggregation occurred from day )2
to day 0. In contrast, no endogenous Sox6 was expressed in the
two P19[anti-Sox6] clones. These results suggest that anti-Sox6
suppressed the transcription or enhanced the degradation of
endogenous Sox6 mRNA.
3.2. Sox6, an essential factor for neuronal diﬀerentiation of P19
cells
P19 cells are known to diﬀerentiate into neuronal cells by
both RA stimulation and cellular aggregation [8,9]. To deter-
mine whether Sox6 expression is essential for neuronal diﬀer-
entiation, P19[anti-Sox6] cells were cultured in accordance
with standard procedures required for neuronal diﬀerentiation
to occur. Brieﬂy, the cells were cultured in bacterial grade
dishes for cellular aggregation in the presence of RA for 4
days, re-plated on poly-ornithine-coated coverslips in the ab-
sence of RA for 5 days, and then ﬁxed for immuno-staining
(Fig. 2). P19[LacZ] cells showed extended neurites and diﬀer-
entiated into MAP2-positive neurons (Fig. 2C). As for
P19[anti-Sox6] cells, most on the coverslips had no neurites
and were not stained by the anti-MAP 2 antibody (Fig. 2A and
B), while morphological observations showed them to be
similar to untreated P19 cells. Further controls are in Sup-
plementary Figure. Oct-3/4, a molecular marker of undiﬀer-
entiated cells, remained expressed in P19[anti-Sox6] cells
during the RA-induction and in monolayer cultures, after
being re-plated in the absence of RA (Fig. 2E). The neuronal
cell markers, Wnt-1, Mash-1, and N-cadherin, were not de-
tected during the culture of P19[anti-Sox6] cells by RT-PCR
(Fig. 2E). These results suggest that anti-Sox6 nearly totally
blocked the neuronal diﬀerentiation of P19 cells.
3.3. Sox6 suppression causes a decrease in cellular aggregation
and RA-dependent cell death
Sox6 mRNA was rapidly increased in P19 cells during RA
stimulation, as we previously described. To examine the eﬀects
of Sox6 suppression, P19[anti-Sox6] cells were observed mor-
phologically during RA stimulation. P19[LacZ] cells formed
many large aggregates in bacterial grade dishes with RA
stimulation (Fig. 3B), whereas P19[anti-Sox6] cells formed few
and small aggregates, with many cellular fragments caused by
the process of cell death (Fig. 3D).
To determine the number of living cells, P19[anti-Sox6] cells
were cultured for 4 days in culture grade dishes in the presence
of RA. Cells that adhered to the dishes were collected after
washing away dead cells and counted using a Coulter counter.
In the absence of RA, two P19[anti-Sox6] cell lines proliferated
in a manner equivalent to P19[LacZ] cells, while in its presence,
P19[anti-Sox6] clones 2–5 proliferated slightly and clones 2–8
did not increase, while the growth of P19[LacZ] cells was half of
that without RA (Fig. 4). Similar results were obtained using
Trypan blue staining for counting after the cells were cultured
for 4 days in bacterial grade dishes in the presence of RA,
though we could not precisely count the number of living cells,
because of the interference of many small cell fragments (data
not shown). As for P19 [anti-Sox6] cells, cell fragments caused
by RA-dependent cell death were seen, whereas such fragments
were not found in the dishes used for P19[LacZ] cells.These results suggest that the low increase in cell number
for P19[anti-Sox6] cells was caused by cell death rather than
a decrease in the rate of cellular proliferation in the presence
of RA.
3.4. Sox6 suppression causes RA-dependent apoptosis
To examine whether RA-induced apoptosis in P19[anti-
Sox6] cells, chromatin condensation was used as an index for
apoptotic cells. Cells were cultured in a ﬂoating state and
stained without ﬁxation using two types of ﬂuorescent re-
agents, Hoechst 33342 for the nuclei of living cells and PI
for those of dead cells. In the absence of RA, P19[LacZ] and
P19[anti-Sox6] cells formed a number of aggregates (Fig. 5A
and D), and contained large and regularly shaped nuclei
with distinct nucleoli that were diﬀusely stained by Hoechst
33342 (Fig. 5B and E). In contrast, in the presence of RA,
Fig. 5. RA-dependent cell death of P19[anti-Sox6] cells. Cells were cultured in 24-well plates as ﬂoating cultures in the presence of RA for 48 h, then
stained with Hoechst 33342 or PI without ﬁxation. Left panels show observations using phase-contrast microscopy. Middle and right panels show
observations after Hoechst 33342 and PI staining, respectively, using ﬂuorescence microscopy. (A–C) P19[LacZ] cells in the absence of RA, (D–F)
clones 2–8 from P19[anti-Sox6] cells in the absence of RA, (G–I) P19[LacZ] cells in the presence of RA, (J–L) clones 2–8 from P19[anti-Sox6] cells in
the presence of RA. Arrows in K show apoptotic nuclei with chromatin condensation. Micrographs show a continuous subset of cells in the same
ﬁelds, which moved slightly because the cells were ﬂoating.
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brightly stained, as well as irregularly shaped nuclei, which is
characteristic of chromatin condensation associated with
apoptosis (Fig. 5K). Almost none of the P19[LacZ] cells
contained such nuclei (Fig. 5H). This remarkable increase in
dead nuclei was also observed following PI staining of
P19[anti-Sox6] cells treated with RA (Fig. 5L), in contrast to
P19[LacZ] cells, which had only a small number of dead
nuclei (Fig. 5I).
To examine cellular viability, cells were cultured in a ﬂoating
state for 4 days in the presence of RA, then collected, and
dispersed by pipetting. The cells were stained with Hoechst
33342 and PI and counted without ﬁxation. The viability rates
of two clones, 2–5 and 2–8, from P19[anti-Sox6] cells and the
P19[LacZ] cells were 22.0 7%, 13.2 4.1%, and 86.6 5.0%,
respectively, at a low concentration of RA (500 nM). Further,
nearly all P19[anti-Sox6] cells died with a high concentration
of RA (1.5 lM), whereas the survival rate of P19[LacZ] cells
was about 70%. In P19[LacZ] cells only slight DNA frag-
mentation (another index of apoptosis) was detected 48 h after
the addition of RA (Fig. 6A), whereas it strengthened over
time in P19[anti-Sox6] cells. DNA fragmentation in P19[anti-
Sox6] cells was also conﬁrmed in experiments that used 33342
or PI for nuclear staining with Hoechst (Fig. 5K and L).
Caspase-3-like activity is known to increase during RA-in-
duced neuronal diﬀerentiation and apoptosis of wild-type P19cells. In the present study, caspase-3-like activity remarkably
increased in RA-treated P19[anti-Sox6] cells, but not in
RA-treated P19[LacZ] cells (Fig. 6B). Overall, chromatin
condensation, DNA fragmentation, and caspase-3-like activity
increased in RA-treated P19[anti-Sox6] cells, showing that the
RA-dependent cell death of P19[anti-Sox6] cells is caused by
apoptosis.4. Discussion
Various factors, including transcriptional factors such as
Mash-1, Ngn-1, and Sox6, are induced by the RA signaling
pathway during neuronal diﬀerentiation of P19 cells [7,9–11].
An important role of the Wnt family, which encodes secretion
proteins associated with morphogenesis in the central nervous
system, has been suggested for P19 cells during RA-induced
neuronal diﬀerentiation [12]. Some transcriptional factors have
been transfected into P19 cells, in which the overexpression of
Wnt-1, Mash-1, and N-cadherin induced neuronal diﬀerenti-
ation, even when RA was not present [7–10,13]. However,
none of these factors were able to play a role equal to RA
when transfected into P19 cells and cellular aggregation was
still required for neuronal diﬀerentiation.
We previously reported that the overexpression of Sox6
caused cellular aggregation and neuronal diﬀerentiation in the
Fig. 6. RA-dependent apoptosis in P19[anti-Sox6] cells. (A) RA-de-
pendent DNA fragmentation in P19[anti-Sox6] cells. Cells were cul-
tured in bacterial grade dishes in the presence of RA for the indicated
times and DNA fragments were collected, as described in Section 2.
DNA ladders were visualized by running 20 ll on a 2% agarose gel,
with a 123-bp ladder used as the standard. (B) Caspase-3-like activity
increased in P19[anti-Sox6] cells with RA-treatment. Cells were cul-
tured in bacterial grade dishes in the presence or absence of RA for 48
h, after which cell extracts were collected, as described in Section 2.
Caspase-3-like activity was measured for 1 h using Ac-DEVD-pNA as
the substrate. Data presented represent meansS.D. of ﬁve replicate
experiments. Diﬀerences were considered signiﬁcant at *P < 0:01 and
**P < 0:05 (Student’s unpaired t test).
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expression of neuronal development-related genes such as
Wnt-1 and Mash-1, and also increased the expression of cell
adhesion molecules such as E-cadherin and N-cadherin. These
results suggest that Sox6 is committed upstream of these fac-
tors in RA-signaling pathways.
In the present study, to examine whether Sox6 expression is
essential for neuronal diﬀerentiation, the anti-Sox6 gene was
transfected into P19 cells to speciﬁcally suppress the Sox6 gene.
Our results showed that P19[anti-Sox6] cells had the same
morphological features and growth rate as RA-untreated P19
cells, and could not diﬀerentiate into MAP2 positive neurons
(Fig. 2). Thus, the suppression of Sox6 blocked the neuronal
diﬀerentiation of P19 cells by RA. Oct-3/4, a molecular marker
of undiﬀerentiated cells, remained expressed in P19[anti-Sox6]
cells during all culture stages. Wnt-1, Mash-1, and N-cadherin,
neuronal cells markers, were not detected during the culture of
P19[anti-Sox6] cells with RA. Though the Wnt-1 has already
and remarkably increased by RA in the neuronal induction
stage of P19 cells, its gene is not completely induced in this
stage for P19[anti-Sox6] cells. These results may suggest that
the suppression of Sox6 inhibits neuronal diﬀerentiation at thestage of neural induction and allows P19 cells remain undif-
ferentiated. In P19[anti-Sox6] cells, aggregates decreased in
number and size, possibly due to a decrease in E-cadherin
expression. Although Sox6 overexpression caused an increase
in N- and E-cadherin expression in P19 cells, the level of E-
cadherin decreased and N-cadherin was not detected in
P19[anti-Sox6] cells in the presence of RA (Fig. 2E and data
not shown). Gao et. al. [10] previously reported that N-
cadherin was increased in RA-induced P19 cells and that its
overexpression caused neuronal diﬀerentiation with cellular
aggregation in the absence of RA. We speculated that a de-
crease in N- or E-cadherin expression is one of the causes of
the failure of neuronal diﬀerentiation by P19[anti-Sox6] cells.
We did not anticipate that Sox6 suppression would cause
RA-dependent cell death in P19[anti-Sox6] cells. RA partially
induces apoptosis in wild-type P19 cells during neuronal dif-
ferentiation. However, most of the P19[anti-Sox6] cells died
after the addition of RA in the present experiments. We
considered that cell death progressed by apoptosis, as it
was accompanied by chromatin condensation and DNA
fragmentation.
The susceptibility of wild-type P19 cells to RA-induced
apoptosis has been reported to be altered by additional en-
dogenous or exogenous substances [14], of which BMP-2 and
4 are cooperative factors [15–17]. Fujita et al. [16] noted that
many apoptotic cells were observed in wild-type P19 cells
treated with both RA and BMP-4. However, they were not
found among those treated with RA or BMP alone. Further,
Tang et al. [13] examined the expression proﬁle of BMP-4 in
wild-type P19 cells and showed that it was not expressed in
P19 cells untreated with RA, while it was increased during
cellular aggregation in the presence of RA and decreased with
the neuronal diﬀerentiation of P19 cells. In that study, re-
markable cell death was not observed even with a higher ex-
pression of BMP-4. In the present results obtained during
cellular aggregation with RA, we also did not observe cell
death in wild-type P19 cells (Fig. 2), but RA-dependent cell
death was seen in P19[anti-Sox6] cells when the expression of
Sox6 was suppressed. Therefore, we considered it important to
examine the expression of BMP-4 in P19[anti-Sox6] cells. In
preliminary experiments, BMP-4 was increased in P19[anti-
Sox6] cells treated with RA. Further, Sox6 may be a gene and
a key for solving this contradiction. Thus, Sox6 may play an
important role in the turning-point at which P19 cells stimu-
lated with RA proceed to cell death or diﬀerentiate into neu-
ronal cells.
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